Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Continuous vs Intermittent AZT in Children with HIV Encephalopathy
NCT00000982Phase 2Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Primary completion
- Sep 1996
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of zidovudine in human immunodeficiency virus infection (HIV), HIV encephalopathy (HAND), sponsored by National Institute of Allergy and Infectious Diseases. Status: completed.
02
Drugs
zidovudine
03
Conditions
human immunodeficiency virus infection (HIV)HIV encephalopathy (HAND)
Beyond the preview
Go deeper on NCT00000982.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00000982.